Predicting deamidation and isomerization sites in therapeutic antibodies using structure-based in silico approaches
Asparagine (Asn) deamidation and aspartic acid (Asp) isomerization are common degradation pathways that affect the stability of therapeutic antibodies. These modifications can pose a significant challenge in the development of biopharmaceuticals. As such, the early engineering and selection of chemi...
Saved in:
Main Authors: | David Hoffmann, Joschka Bauer, Markus Kossner, Andrew Henry, Anne R. Karow-Zwick, Giuseppe Licari |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | mAbs |
Subjects: | |
Online Access: | https://www.tandfonline.com/doi/10.1080/19420862.2024.2333436 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Isomerization and degradation of all-trans-β-carotene during in-vitro digestion
by: Wenyang Tao, et al.
Published: (2021-05-01) -
Editorial: The immune response to therapeutic antibodies
by: Michael G. Tovey, et al.
Published: (2025-02-01) -
Molecular surface descriptors to predict antibody developability: sensitivity to parameters, structure models, and conformational sampling
by: Eliott Park, et al.
Published: (2024-12-01) -
Assessment and incorporation of in vitro correlates to pharmacokinetic outcomes in antibody developability workflows
by: Tushar Jain, et al.
Published: (2024-12-01) -
Nonclinical immunogenicity risk assessment for knobs-into-holes bispecific IgG1 antibodies
by: Wen-Ting K. Tsai, et al.
Published: (2024-12-01)